GSK plans to launch five cancer drugs by 2010

GlaxoSmithKline expects to launch five new cancer drugs within the next three years, the firm announced. By 2010, GSK expects to be marketing Promacta to reduce bleeding and help cancer patients build up their platelet count; Ofatumumab, an antibody to treat leukemia; Cervarix for cervical cancer; Pazopanib for renal cancer; and Rezonic for chemotherapy nausea.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL